Gilead News
Gilead Wins as Judge Reverses Record $2.54B Hepatitis C Drug Patent Verdict
A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc. to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by ...